Pharmaceuticals

Papers
(The H4-Index of Pharmaceuticals is 52. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)
ArticleCitations
Antibody–Drug Conjugates: The Last Decade209
The Treatment of Impaired Wound Healing in Diabetes: Looking among Old Drugs181
Curcumin, a Natural Antimicrobial Agent with Strain-Specific Activity145
FDA-Approved Drugs with Potent In Vitro Antiviral Activity against Severe Acute Respiratory Syndrome Coronavirus 2108
Towards Better Delivery of Cannabidiol (CBD)106
Status and Challenges of Plant-Anticancer Compounds in Cancer Treatment106
Lung Fibrosis after COVID-19: Treatment Prospects105
Overcoming Barriers for siRNA Therapeutics: From Bench to Bedside105
Avermectin Derivatives, Pharmacokinetics, Therapeutic and Toxic Dosages, Mechanism of Action, and Their Biological Effects103
Network Pharmacology Approach for Medicinal Plants: Review and Assessment101
Dietary Effects of Anthocyanins in Human Health: A Comprehensive Review96
Novel 1,2,4-Oxadiazole Derivatives in Drug Discovery93
COVID-19 Vaccines: A Review of the Safety and Efficacy of Current Clinical Trials92
Treatment of Alzheimer’s Disease and Blood–Brain Barrier Drug Delivery91
1,2,4-Triazoles as Important Antibacterial Agents91
Pharmaceutical Drugs and Natural Therapeutic Products for the Treatment of Type 2 Diabetes Mellitus87
Current Insights on Antifungal Therapy: Novel Nanotechnology Approaches for Drug Delivery Systems and New Drugs from Natural Sources84
Atypical Antipsychotics and Metabolic Syndrome: From Molecular Mechanisms to Clinical Differences83
Substance Use Disorder in the COVID-19 Pandemic: A Systematic Review of Vulnerabilities and Complications81
Antibacterials in Aquatic Environment and Their Toxicity to Fish77
Pharmacological Treatments for Patients with Treatment-Resistant Depression76
Alginate Nanoformulation: Influence of Process and Selected Variables75
Mycosporine-Like Amino Acids (MAAs): Biology, Chemistry and Identification Features75
Phage Cocktail Development for Bacteriophage Therapy: Toward Improving Spectrum of Activity Breadth and Depth74
Drug Design by Pharmacophore and Virtual Screening Approach72
Formulation Design, Statistical Optimization, and In Vitro Evaluation of a Naringenin Nanoemulsion to Enhance Apoptotic Activity in A549 Lung Cancer Cells69
Side Effects of mRNA-Based COVID-19 Vaccine: Nationwide Phase IV Study among Healthcare Workers in Slovakia68
Emerging Applications of Nanotechnology in Healthcare Systems: Grand Challenges and Perspectives68
Opioid Analgesia and Opioid-Induced Adverse Effects: A Review68
Bone Tissue Engineering in the Treatment of Bone Defects64
[177Lu]Lu-PSMA-617 (PluvictoTM): The First FDA-Approved Radiotherapeutical for Treatment of Prostate Cancer64
The Role of AI in Drug Discovery: Challenges, Opportunities, and Strategies62
Serum Extracellular Vesicle-Derived circHIPK3 and circSMARCA5 Are Two Novel Diagnostic Biomarkers for Glioblastoma Multiforme62
Silica-Based Bioactive Glasses and Their Applications in Hard Tissue Regeneration: A Review60
Identification of Novel Cyanopyridones and Pyrido[2,3-d]Pyrimidines as Anticancer Agents with Dual VEGFR-2/HER-2 Inhibitory Action: Synthesis, Biological Evaluation and Molecular Docking Studies59
The Boron Advantage: The Evolution and Diversification of Boron’s Applications in Medicinal Chemistry58
Parthenolide as Cooperating Agent for Anti-Cancer Treatment of Various Malignancies58
The Chemistry Behind ADCs58
The Current and Potential Therapeutic Use of Metformin—The Good Old Drug57
Microneedle-Based Natural Polysaccharide for Drug Delivery Systems (DDS): Progress and Challenges57
[68Ga]Ga-PSMA-11: The First FDA-Approved 68Ga-Radiopharmaceutical for PET Imaging of Prostate Cancer56
G-Quadruplexes and Their Ligands: Biophysical Methods to Unravel G-Quadruplex/Ligand Interactions56
Autophagy as a Potential Therapy for Malignant Glioma56
Tauvid™: The First FDA-Approved PET Tracer for Imaging Tau Pathology in Alzheimer’s Disease55
Covalently Functionalized Carbon Nano-Onions Integrated Gelatin Methacryloyl Nanocomposite Hydrogel Containing γ-Cyclodextrin as Drug Carrier for High-Performance pH-Triggered Drug Release55
TIGIT/CD226 Axis Regulates Anti-Tumor Immunity55
Perspective of SGLT2 Inhibition in Treatment of Conditions Connected to Neuronal Loss: Focus on Alzheimer’s Disease and Ischemia-Related Brain Injury54
An Overview of Cellulose Derivatives-Based Dressings for Wound-Healing Management54
Current Therapies in Clinical Trials of Parkinson’s Disease: A 2021 Update53
Alpha-Synuclein PET Tracer Development—An Overview about Current Efforts53
Periodontal Wound Healing and Tissue Regeneration: A Narrative Review53
Phytochemicals from Plant Foods as Potential Source of Antiviral Agents: An Overview52
0.02805495262146